909 related articles for article (PubMed ID: 18273624)
21. Distribution of cerebral amyloid deposition and its relevance to clinical phenotype in Lewy body dementia.
Fujishiro H; Iseki E; Higashi S; Kasanuki K; Murayama N; Togo T; Katsuse O; Uchikado H; Aoki N; Kosaka K; Arai H; Sato K
Neurosci Lett; 2010 Dec; 486(1):19-23. PubMed ID: 20851165
[TBL] [Abstract][Full Text] [Related]
22. Olfactory tau pathology in Alzheimer disease and mild cognitive impairment.
Attems J; Jellinger KA
Clin Neuropathol; 2006; 25(6):265-71. PubMed ID: 17140156
[TBL] [Abstract][Full Text] [Related]
23. Cognitive profiles of individual patients with Parkinson's disease and dementia: comparison with dementia with lewy bodies and Alzheimer's disease.
Janvin CC; Larsen JP; Salmon DP; Galasko D; Hugdahl K; Aarsland D
Mov Disord; 2006 Mar; 21(3):337-42. PubMed ID: 16211595
[TBL] [Abstract][Full Text] [Related]
24. Prevalence and impact of cerebrovascular pathology in Alzheimer's disease and parkinsonism.
Jellinger KA; Attems J
Acta Neurol Scand; 2006 Jul; 114(1):38-46. PubMed ID: 16774626
[TBL] [Abstract][Full Text] [Related]
25. Neuropathology of Parkinson's disease dementia and dementia with Lewy bodies with reference to striatal pathology.
Tsuboi Y; Uchikado H; Dickson DW
Parkinsonism Relat Disord; 2007; 13 Suppl 3():S221-4. PubMed ID: 18267239
[TBL] [Abstract][Full Text] [Related]
26. Only cerebral capillary amyloid angiopathy correlates with Alzheimer pathology--a pilot study.
Attems J; Jellinger KA
Acta Neuropathol; 2004 Feb; 107(2):83-90. PubMed ID: 14655019
[TBL] [Abstract][Full Text] [Related]
27. Cerebrospinal fluid markers in dementia with lewy bodies compared with Alzheimer disease.
Gómez-Tortosa E; Gonzalo I; Fanjul S; Sainz MJ; Cantarero S; Cemillán C; Yébenes JG; del Ser T
Arch Neurol; 2003 Sep; 60(9):1218-22. PubMed ID: 12975286
[TBL] [Abstract][Full Text] [Related]
28. EEG comparisons in early Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease with dementia patients with a 2-year follow-up.
Bonanni L; Thomas A; Tiraboschi P; Perfetti B; Varanese S; Onofrj M
Brain; 2008 Mar; 131(Pt 3):690-705. PubMed ID: 18202105
[TBL] [Abstract][Full Text] [Related]
29. Clinical phenotype of Parkinson disease dementia.
Galvin JE; Pollack J; Morris JC
Neurology; 2006 Nov; 67(9):1605-11. PubMed ID: 17101891
[TBL] [Abstract][Full Text] [Related]
30. Relationship of phosphorylated alpha-synuclein and tau accumulation to Abeta deposition in the cerebral cortex of dementia with Lewy bodies.
Obi K; Akiyama H; Kondo H; Shimomura Y; Hasegawa M; Iwatsubo T; Mizuno Y; Mochizuki H
Exp Neurol; 2008 Apr; 210(2):409-20. PubMed ID: 18164295
[TBL] [Abstract][Full Text] [Related]
31. APOE, vascular pathology, and the AD brain.
Yip AG; McKee AC; Green RC; Wells J; Young H; Cupples LA; Farrer LA
Neurology; 2005 Jul; 65(2):259-65. PubMed ID: 16043796
[TBL] [Abstract][Full Text] [Related]
32. Lewy bodies in the amygdala increase risk for major depression in subjects with Alzheimer disease.
Lopez OL; Becker JT; Sweet RA; Martin-Sanchez FJ; Hamilton RL
Neurology; 2006 Aug; 67(4):660-5. PubMed ID: 16924019
[TBL] [Abstract][Full Text] [Related]
33. Prevalence, distribution, and severity of cerebral amyloid angiopathy differ between Lewy body diseases and Alzheimer's disease.
Walker L; Simpson H; Thomas AJ; Attems J
Acta Neuropathol Commun; 2024 Feb; 12(1):28. PubMed ID: 38360761
[TBL] [Abstract][Full Text] [Related]
34. Dementia with Lewy bodies and Parkinson's disease with dementia: are they different?
Tsuboi Y; Dickson DW
Parkinsonism Relat Disord; 2005 Jun; 11 Suppl 1():S47-51. PubMed ID: 15885629
[TBL] [Abstract][Full Text] [Related]
35. Significance of cerebral amyloid angiopathy and other co-morbidities in Lewy body diseases.
Jellinger KA
J Neural Transm (Vienna); 2021 May; 128(5):687-699. PubMed ID: 33928445
[TBL] [Abstract][Full Text] [Related]
36. Pentagon drawing and neuropsychological performance in Dementia with Lewy Bodies, Alzheimer's disease, Parkinson's disease and Parkinson's disease with dementia.
Cormack F; Aarsland D; Ballard C; Tovée MJ
Int J Geriatr Psychiatry; 2004 Apr; 19(4):371-7. PubMed ID: 15065231
[TBL] [Abstract][Full Text] [Related]
37. Biochemical staging of synucleinopathy and amyloid deposition in dementia with Lewy bodies.
Deramecourt V; Bombois S; Maurage CA; Ghestem A; Drobecq H; Vanmechelen E; Lebert F; Pasquier F; Delacourte A
J Neuropathol Exp Neurol; 2006 Mar; 65(3):278-88. PubMed ID: 16651889
[TBL] [Abstract][Full Text] [Related]
38. CSF alpha-synuclein levels in dementia with Lewy bodies and Alzheimer's disease.
Noguchi-Shinohara M; Tokuda T; Yoshita M; Kasai T; Ono K; Nakagawa M; El-Agnaf OM; Yamada M
Brain Res; 2009 Jan; 1251():1-6. PubMed ID: 19071095
[TBL] [Abstract][Full Text] [Related]
39. Cohort study on somatoform disorders in Parkinson disease and dementia with Lewy bodies.
Onofrj M; Bonanni L; Manzoli L; Thomas A
Neurology; 2010 May; 74(20):1598-606. PubMed ID: 20479358
[TBL] [Abstract][Full Text] [Related]
40. Comparison of dementia with Lewy bodies to Alzheimer's disease and Parkinson's disease with dementia.
Noe E; Marder K; Bell KL; Jacobs DM; Manly JJ; Stern Y
Mov Disord; 2004 Jan; 19(1):60-7. PubMed ID: 14743362
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
